COVID-19对机器人后鞘前腹壁疝修补术临床结局的影响
本研究回顾性比较了COVID-19大流行前后接受机器人后鞘前腹壁疝修补术(rRVHR)患者的临床结局。结果显示两组住院时间中位数均为0天,术后并发症发生率无显著差异,未记录到疝复发,提示疫情未改变该术式的医疗及疝特异性并发症。
要点
- rRVHR术后住院时间中位数为0天,疫情前后无差异。
- 疫情前后术后并发症发生率无显著差异(p=0.88)。
- 两组均未记录到疝复发。
核心结论
- COVID-19大流行未改变机器人后鞘前腹壁疝修补术的住院时间及医疗和疝特异性并发症发生率。
研究设计与样本
- 回顾性研究,纳入2020年3月10日前600天及后600天内接受rRVHR的患者,分为疫情前组(153例,46%女性)和疫情后组(141例,51%女性)。
主要发现
- 疫情前组和疫情后组中位年龄分别为57岁(48-68)和55岁(42-64),差异有统计学意义(p=0.045)。
- 两组住院时间中位数均为0天(0-1),当日出院率分别为61%和70%(p=0.09)。
- 疫情前组26例术后并发症(其中7例肺部并发症),疫情后组23例并发症(其中3例肺部并发症),差异无统计学意义(p=0.88)。
- 两组手术部位事件发生率相当,均未记录到疝复发。
- 平均术后随访时间为39.2个月(4.1-93.6)。
临床怎么用
- 在疫情等医疗资源受限情况下,rRVHR仍可安全开展,住院时间和并发症风险未增加。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic disrupted the healthcare sector and forced hospitals to limit the number of elective procedures with the goal of reducing overcrowding of wards and thus viral transmission. Recent trends for ventral hernia repair have shifted towards retromuscular techniques, which normally require a longer length of stay. Therefore, the aim of this study is to investigate the impact of the COVID-19 pandemic on clinical outcomes of robotic retromuscular ventral hernia repair (rRVHR). METHODS: Patients who underwent rRVHR up to 600 days before and after March 10, 2020, were included in this retrospective study and assigned to the pre- or post-COVID group depending on the date of their procedure. Pre-, intra-, and postoperative variables including patients' demographics, hernia characteristics, complications, and hernia recurrence were compared between both groups. RESULTS: 153 (46% female) and 141 (51% female) patients were assigned to the pre- and post-COVID groups respectively. Median age was statistically different between both groups [pre-COVID: 57 (48-68) vs. post-COVID 55 (42-64) years, p = 0.045]. Median hospital length of stay (LOS) was 0 day (0-1) in both groups, and same day discharge were 61% pre-pandemic and 70% post-pandemic (p = 0.09). Mean postoperative follow-up was 39.2 (4.1-93.6) months. In total, 26 pre-COVID patients had postoperative complications, out of which 7 were pulmonary complications, whereas 23 complications were recorded in the post-COVID group, with only 3 pulmonary complications (p = 0.88). Rate of surgical-site events was comparable between both groups, and no recurrences were recorded. CONCLUSION: This is the first study to describe the impact of the COVID-19 on rRVHR. Hospital LOS was comparable between both groups. Rates of medical and hernia specific complications were not altered by the pandemic.
引用
- Kudsi OY, Kaoukabani G, Bou-Ayash N, et al. Impact of COVID-19 on clinical outcomes of robotic retromuscular ventral hernia repair. Surg Endosc. 2022. PMID: 36085385. doi:10.1007/s00464-022-09607-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。